Definitive Healthcare (NASDAQ:DH) Issues FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 0.340-0.350 for the period, compared to the consensus EPS estimate of 0.330. The company issued revenue guidance of $250.0 million-$251.0 million, compared to the consensus revenue estimate of $249.2 million. Definitive Healthcare also updated its Q4 guidance to $0.07 EPS.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock traded down $0.07 during mid-day trading on Friday, hitting $4.24. 1,200,343 shares of the stock were exchanged, compared to its average volume of 326,752. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62. The company has a 50-day simple moving average of $4.36 and a 200 day simple moving average of $4.98. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.40 and a current ratio of 2.40. The company has a market capitalization of $500.02 million, a P/E ratio of -1.22, a P/E/G ratio of 6.27 and a beta of 1.33.

Analyst Ratings Changes

Several brokerages have recently issued reports on DH. Stifel Nicolaus decreased their price target on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research note on Wednesday, July 31st. Barclays decreased their price target on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 7th. BTIG Research initiated coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective for the company. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Friday. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $5.81.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.